George Yancopoulos (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "George Yancopoulos" in English language version.

refsWebsite

Global rank English rank

12nih.gov

4^th place

10doi.org

2^nd place

6semanticscholar.org

11^th place

8^th place

4harvard.edu

18^th place

17^th place

3regeneron.com

low place

3nytimes.com

7^th place

3forbes.com

54^th place

48^th place

3columbia.edu

488^th place

374^th place

2yale.edu

565^th place

460^th place

1web.archive.org

1^st place

1reuters.com

49^th place

47^th place

1uspto.gov

1,459^th place

991^st place

1seekingalpha.com

5,344^th place

3,420^th place

1wsj.com

79^th place

65^th place

1scientificamerican.com

896^th place

674^th place

1jimmunol.org

low place

1nasonline.org

3,325^th place

2,396^th place

1nature.com

234^th place

397^th place

1bloomberg.com

99^th place

77^th place

1societyforscience.org

low place

1genengnews.com

low place

6,625^th place

1rockefeller.edu

low place

1burke.org

low place

1westfaironline.com

low place

1lifesci.nyc

low place

1thesciencesurvey.com

low place

1fliphtml5.com

low place

1nyipla.org

low place

1cshl.edu

low place

1acgtfoundation.org

low place

1srfcure.org

low place

1psscra.org

low place

1barrons.com

2,737^th place

1,700^th place

1science.org

1,160^th place

737^th place

1fda.gov

447^th place

338^th place

acgtfoundation.org

"George D. Yancopoulos, MD, PhD". Alliance for Cancer Gene Therapy. October 12, 2022. Retrieved October 12, 2022.

barrons.com

"Alison Bateman-House, et al. (October 8, 2020) "Trump's Regeneron Treatment Is a Tangled Ethical Mess" Barron's".

bloomberg.com

"George D. Yancopoulos". Bloomberg L.P. Retrieved July 23, 2018.

burke.org

"Dr. George D. Yancopoulos, Founding Scientist, Regeneron Laboratories, to Be Honored by Burke Rehabilitation Center". Burke Rehabilitation Hospital. 3 June 2013. Retrieved June 3, 2013.

columbia.edu

cc-seas.columbia.edu

"Cusp Speaker Series Presents: 2005–2006".

college.columbia.edu

"Dr. George D. Yancopoulos CC'80, GSAS'86, VPS'87 honored at Alexander Hamilton Dinner". Columbia College. November 22, 2019.

cuimc.columbia.edu

"Leadership and Administration". Columbia University. October 12, 2022. Retrieved October 12, 2022.

cshl.edu

"Regeneron's Dr. George D. Yancopoulos elected to Cold Spring Harbor Laboratory Board of Trustees". Cold Spring Harbor Laboratory. October 12, 2022. Retrieved October 12, 2022.

doi.org

Michael S. Krangel (December 1, 2015). "Beyond Hypothesis: Direct Evidence That V(D)J Recombination Is Regulated by the Accessibility of Chromatin Substrates". Journal of Immunology. 195 (11): 5103–5105. doi:10.4049/jimmunol.1502150. PMID 26589747. S2CID 39216064.
Maisonpierre PC, Belluscio L, Squinto S, et al. (March 1990). "Neurotrophin-3: a neurotrophic factor related to NGF and BDNF". Science. 247 (4949 Pt 1): 1446–51. Bibcode:1990Sci...247.1446M. doi:10.1126/science.2321006. PMID 2321006. S2CID 37763746.
Glass DJ, Nye SH, Hantzopoulos P, et al. (July 1991). "TrkB mediates BDNF/NT-3-dependent survival and proliferation in fibroblasts lacking the low affinity NGF receptor". Cell. 66 (2): 405–13. doi:10.1016/0092-8674(91)90629-D. PMID 1649703. S2CID 43626580.
DeChiara TM, Bowen DC, Valenzuela DM, et al. (May 1996). "The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo". Cell. 85 (4): 501–12. doi:10.1016/S0092-8674(00)81251-9. PMID 8653786. S2CID 17455481.
Glass DJ, Bowen DC, Stitt TN, et al. (May 1996). "Agrin acts via a MuSK receptor complex". Cell. 85 (4): 513–523. doi:10.1016/S0092-8674(00)81252-0. PMID 8653787. S2CID 14930468.
Davis S, Aldrich TH, Valenzuela DM, et al. (July 1991). "The receptor for ciliary neurotrophic factor". Science. 253 (5015): 59–63. Bibcode:1991Sci...253...59D. doi:10.1126/science.1648265. PMID 1648265.
Economides AN, Carpenter LR, Rudge JS, et al. (January 2003). "Cytokine traps: multi-component, high-affinity blockers of cytokine action". Nature Medicine. 9 (1): 47–52. doi:10.1038/nm811. PMID 12483208. S2CID 6541399.
Holash J, Davis S, Papadopoulos N, et al. (August 2002). "VEGF-Trap: a VEGF blocker with potent antitumor effects". Proceedings of the National Academy of Sciences of the United States of America. 99 (17): 11393–11398. Bibcode:2002PNAS...9911393H. doi:10.1073/pnas.172398299. PMC 123267. PMID 12177445.
Mullard, Asher (2020). "FDA approves antibody cocktail for Ebola virus". Nature Reviews Drug Discovery. 19 (12): 827. doi:10.1038/d41573-020-00197-8. PMID 33144717.
Hansen, J.; et al. (2020). "Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail". Science. 369 (6506): 1010–1014. Bibcode:2020Sci...369.1010H. doi:10.1126/science.abd0827. PMC 7299284. PMID 32540901.

fda.gov

accessdata.fda.gov

"CFR – Code of Federal Regulations Title 21". U.S. Food & Drug Administration.

fliphtml5.com

online.fliphtml5.com

"Laureates since 2007". The Galien Foundation. October 13, 2022. Retrieved October 13, 2022.

forbes.com

Matthew Herper (August 14, 2013). "How Two Guys From Queens Are Changing Drug Discovery". Forbes.
Mathew, Herper. "Regeneron's George Yancopoulos Becomes Pharma's First Billionaire R&D Chief". forbes.com. Retrieved 28 July 2015.
"#20 George Yancopoulos". Forbes. April 20, 2020.

genengnews.com

Alex Philippidis (November 15, 2017). "Regeneron Genetics Center Surpasses 250K Exomes Sequenced, and Ramping Up". Genetic Engineering & Biotechnology News.

harvard.edu

ui.adsabs.harvard.edu

Maisonpierre PC, Belluscio L, Squinto S, et al. (March 1990). "Neurotrophin-3: a neurotrophic factor related to NGF and BDNF". Science. 247 (4949 Pt 1): 1446–51. Bibcode:1990Sci...247.1446M. doi:10.1126/science.2321006. PMID 2321006. S2CID 37763746.
Davis S, Aldrich TH, Valenzuela DM, et al. (July 1991). "The receptor for ciliary neurotrophic factor". Science. 253 (5015): 59–63. Bibcode:1991Sci...253...59D. doi:10.1126/science.1648265. PMID 1648265.
Holash J, Davis S, Papadopoulos N, et al. (August 2002). "VEGF-Trap: a VEGF blocker with potent antitumor effects". Proceedings of the National Academy of Sciences of the United States of America. 99 (17): 11393–11398. Bibcode:2002PNAS...9911393H. doi:10.1073/pnas.172398299. PMC 123267. PMID 12177445.
Hansen, J.; et al. (2020). "Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail". Science. 369 (6506): 1010–1014. Bibcode:2020Sci...369.1010H. doi:10.1126/science.abd0827. PMC 7299284. PMID 32540901.

jimmunol.org

Michael S. Krangel (December 1, 2015). "Beyond Hypothesis: Direct Evidence That V(D)J Recombination Is Regulated by the Accessibility of Chromatin Substrates". Journal of Immunology. 195 (11): 5103–5105. doi:10.4049/jimmunol.1502150. PMID 26589747. S2CID 39216064.

lifesci.nyc

"Advisory Council: George D. Yancopoulos, MD, PhD". LifeSci NYC. Retrieved July 31, 2018.

nasonline.org

"George D. Yancopoulos". National Academy of Sciences. Retrieved September 17, 2018.

nature.com

Mullard, Asher (2020). "FDA approves antibody cocktail for Ebola virus". Nature Reviews Drug Discovery. 19 (12): 827. doi:10.1038/d41573-020-00197-8. PMID 33144717.

nih.gov

pubmed.ncbi.nlm.nih.gov

Michael S. Krangel (December 1, 2015). "Beyond Hypothesis: Direct Evidence That V(D)J Recombination Is Regulated by the Accessibility of Chromatin Substrates". Journal of Immunology. 195 (11): 5103–5105. doi:10.4049/jimmunol.1502150. PMID 26589747. S2CID 39216064.
Maisonpierre PC, Belluscio L, Squinto S, et al. (March 1990). "Neurotrophin-3: a neurotrophic factor related to NGF and BDNF". Science. 247 (4949 Pt 1): 1446–51. Bibcode:1990Sci...247.1446M. doi:10.1126/science.2321006. PMID 2321006. S2CID 37763746.
Glass DJ, Nye SH, Hantzopoulos P, et al. (July 1991). "TrkB mediates BDNF/NT-3-dependent survival and proliferation in fibroblasts lacking the low affinity NGF receptor". Cell. 66 (2): 405–13. doi:10.1016/0092-8674(91)90629-D. PMID 1649703. S2CID 43626580.
DeChiara TM, Bowen DC, Valenzuela DM, et al. (May 1996). "The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo". Cell. 85 (4): 501–12. doi:10.1016/S0092-8674(00)81251-9. PMID 8653786. S2CID 17455481.
Glass DJ, Bowen DC, Stitt TN, et al. (May 1996). "Agrin acts via a MuSK receptor complex". Cell. 85 (4): 513–523. doi:10.1016/S0092-8674(00)81252-0. PMID 8653787. S2CID 14930468.
Davis S, Aldrich TH, Valenzuela DM, et al. (July 1991). "The receptor for ciliary neurotrophic factor". Science. 253 (5015): 59–63. Bibcode:1991Sci...253...59D. doi:10.1126/science.1648265. PMID 1648265.
Economides AN, Carpenter LR, Rudge JS, et al. (January 2003). "Cytokine traps: multi-component, high-affinity blockers of cytokine action". Nature Medicine. 9 (1): 47–52. doi:10.1038/nm811. PMID 12483208. S2CID 6541399.
Holash J, Davis S, Papadopoulos N, et al. (August 2002). "VEGF-Trap: a VEGF blocker with potent antitumor effects". Proceedings of the National Academy of Sciences of the United States of America. 99 (17): 11393–11398. Bibcode:2002PNAS...9911393H. doi:10.1073/pnas.172398299. PMC 123267. PMID 12177445.
Mullard, Asher (2020). "FDA approves antibody cocktail for Ebola virus". Nature Reviews Drug Discovery. 19 (12): 827. doi:10.1038/d41573-020-00197-8. PMID 33144717.
Hansen, J.; et al. (2020). "Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail". Science. 369 (6506): 1010–1014. Bibcode:2020Sci...369.1010H. doi:10.1126/science.abd0827. PMC 7299284. PMID 32540901.

ncbi.nlm.nih.gov

Holash J, Davis S, Papadopoulos N, et al. (August 2002). "VEGF-Trap: a VEGF blocker with potent antitumor effects". Proceedings of the National Academy of Sciences of the United States of America. 99 (17): 11393–11398. Bibcode:2002PNAS...9911393H. doi:10.1073/pnas.172398299. PMC 123267. PMID 12177445.
Hansen, J.; et al. (2020). "Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail". Science. 369 (6506): 1010–1014. Bibcode:2020Sci...369.1010H. doi:10.1126/science.abd0827. PMC 7299284. PMID 32540901.

nyipla.org

"Inventor of the Year Award". The New York Intellectual Property Law Association. October 13, 2022. Retrieved October 13, 2022.

nytimes.com

"How Nerve Meets Muscle and Begins to Talk". New York Times. May 21, 1996. Retrieved May 1, 2011.
Stolberg, Sheryl Gay (10 December 2020). "Sheryl Gay Stolberg (December 9, 2020) "Trump and Friends Got Coronavirus Care Many Others Couldn't" The New York Times". The New York Times.
Goodman, J. David; Ferré-Sadurní, Luis; McKinley, Jesse (25 March 2021). "J. David Goodman, et al. (March 25, 2021) "Executive With Ties to Cuomo Got Special Access to Virus Testing" The New York Times". The New York Times.

psscra.org

"Prize Advisory Board". Pershing Square Sohn Cancer Research Alliance. October 12, 2022. Retrieved October 12, 2022.

regeneron.com

"Our Team". Regeneron Pharmaceuticals. Retrieved July 26, 2018.
"Regeneron Genetics Center". 2023.
"Our Rapid Response to COVID-19". Regeneron Pharmaceuticals.

reuters.com

uk.reuters.com

"Exclusive: Biotech Regeneron on verge of big leagues". Reuters. May 12, 2010. Archived from the original on March 5, 2016. Retrieved May 1, 2011.

rockefeller.edu

"Marc Tessier-Lavigne receives lifetime achievement award from biotech executives".

science.org

"Jon Cohen (October 5, 2020) "Update: Here's what is known about Trump's COVID-19 treatment" Science". Science.

scientificamerican.com

"George Yancopoulos: Doing Well by Trying to Do Good". Scientific American. October 6, 2008. Retrieved May 1, 2011.

seekingalpha.com

Toni Nasr (February 5, 2018). "Regeneron Investment: Healthcare With Wealthcare". Seeking Alpha.

semanticscholar.org

api.semanticscholar.org

Michael S. Krangel (December 1, 2015). "Beyond Hypothesis: Direct Evidence That V(D)J Recombination Is Regulated by the Accessibility of Chromatin Substrates". Journal of Immunology. 195 (11): 5103–5105. doi:10.4049/jimmunol.1502150. PMID 26589747. S2CID 39216064.
Maisonpierre PC, Belluscio L, Squinto S, et al. (March 1990). "Neurotrophin-3: a neurotrophic factor related to NGF and BDNF". Science. 247 (4949 Pt 1): 1446–51. Bibcode:1990Sci...247.1446M. doi:10.1126/science.2321006. PMID 2321006. S2CID 37763746.
Glass DJ, Nye SH, Hantzopoulos P, et al. (July 1991). "TrkB mediates BDNF/NT-3-dependent survival and proliferation in fibroblasts lacking the low affinity NGF receptor". Cell. 66 (2): 405–13. doi:10.1016/0092-8674(91)90629-D. PMID 1649703. S2CID 43626580.
DeChiara TM, Bowen DC, Valenzuela DM, et al. (May 1996). "The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo". Cell. 85 (4): 501–12. doi:10.1016/S0092-8674(00)81251-9. PMID 8653786. S2CID 17455481.
Glass DJ, Bowen DC, Stitt TN, et al. (May 1996). "Agrin acts via a MuSK receptor complex". Cell. 85 (4): 513–523. doi:10.1016/S0092-8674(00)81252-0. PMID 8653787. S2CID 14930468.
Economides AN, Carpenter LR, Rudge JS, et al. (January 2003). "Cytokine traps: multi-component, high-affinity blockers of cytokine action". Nature Medicine. 9 (1): 47–52. doi:10.1038/nm811. PMID 12483208. S2CID 6541399.

societyforscience.org

student.societyforscience.org

"Regeneron Founded by Two STS Alumni". Society for Science & the Public. Retrieved July 27, 2018.

srfcure.org

"Bio". Scleroderma Research Foundation. October 12, 2022. Retrieved October 12, 2022.

thesciencesurvey.com

Sofie Levine (May 30, 2018). "George Yancopoulos '76". The Science Survey.

uspto.gov

patft.uspto.gov

"George Yancopoulos". United States Patent and Trademark Office. Retrieved July 25, 2018.

web.archive.org

"Exclusive: Biotech Regeneron on verge of big leagues". Reuters. May 12, 2010. Archived from the original on March 5, 2016. Retrieved May 1, 2011.

westfaironline.com

John Golden (November 22, 2016). "Regeneron's Schleifer, Yancopoulos share Entrepreneur of Year award". Westfair Online.

wsj.com

Ron Winslow (May 26, 2016). "Regeneron Named as Science Talent Search Sponsor". The Wall Street Journal.

yale.edu

som.yale.edu

"Legend in Leadership Recipients". Yale School of Management. December 15, 2017.
"#8 George Yancopoulos". Fortune. April 20, 2020.